In Iran, there are more than 85 pharmaceutical manufacturers; 20 active pharmaceutical ingredients manufacturers (API) and several knowledge-based, mostly biopharmaceutical, companies and the largest manufacturer has 11.5% of the market. There are 15 national and many regional wholesalers and more than 8000 retail pharmacies and some 800 hospital pharmacies are serving patients.  The pharmaceutical market is largely a generic market and domestic industry supplies have very low and fixed prices. There are trade barriers against importers (tariffs up to 65% for branded medicines which are also locally produced). Read More ...

Arya Diba Darou was established in 2011 as a member of Shiraz Group, to enter Iranian market as a leading, fast growing formulation company. Since the beginning, Diba Darou has set the goal to to attain and hold a leadership position in the business with strong, sustainable performance based on innovation and productivity. Read More ...